Supplementary Table 2.
Baseline characteristics of patients in FPC transfusion group and no blood transfusion group in a propensity score model.
| Variable | FPC group (n=188) | No transfusion group (n=188) | p Value |
|---|---|---|---|
| Male gender | 153 (81.4%) | 149 (79.3%) | 0.604 |
| Age (year) | 53±12 | 54±12 | 0.367 |
| Body mass index (kg/m2) | 22.7±3.4 | 22.9±3.0 | 0.623 |
| Cigarette smoking | 78 (41.5%) | 76 (40.4%) | 0.834 |
| Diabetes mellitus | 18 (9.6%) | 18 (9.6%) | 1.000 |
| HBV/HCV positive | 128 (68.1%) | 143 (76.1%) | 0.107 |
| Cardiovascular disease | 25 (13.3%) | 30 (16%) | 0.466 |
| Child-Pugh class | 0.337 | ||
| A | 181 (96.3%) | 185 (98.4%) | |
| B | 7 (3.7%) | 3 (1.6%) | |
| ASA classification | 0.117 | ||
| 1 | 7 (3.7%) | 6 (3.2%) | |
| 2 | 133 (70.7%) | 150 (79.8%) | |
| 3 | 48 (25.5%) | 32 (17%) | |
| ICG 15min retention (%) | 9.9±8.2 | 10.3±15.1 | 0.895 |
| Hepatic inflow occlusion | 136 (72.3%) | 131 (69.7%) | 0.570 |
| Tumor location | 0.247 | ||
| Left lobe | 48 (25.5%) | 44 (23.4%) | |
| Right lobe | 129 (68.6%) | 139 (73.9%) | |
| Bilobar involvement | 11 (5.9%) | 5 (2.7%) | |
| Primary disease | 0.778 | ||
| Hepatocellular carcinoma | 164 (87.2%) | 167 (88.8%) | |
| Intrahepatic cholangiocarcinoma | 13 (6.9%) | 13 (6.9%) | |
| Other liver malignancies | 11 (5.9%) | 8 (4.3%) | |
| Surgical procedures | 0.578 | ||
| Minor hepatectomy | 159 (84.6%) | 155 (82.4%) | |
| Major hepatectomy | 29 (15.4%) | 33 (17.6%) |
FPC – frozen fresh plasma, platelet and cryoprecipitate; HBV – hepatitis B virus; HCV – hepatitis C virus; ASA – the American Society of Anesthesiologists; ICG – indocyanine green.